Robert Lambkin-Williams

6PUBLICATIONS
9CO-AUTHORS
Medical virologyPredictive and prognostic markersMedical infection agents (incl. prions)Cancer diagnosisSpeciation and extinction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2020
Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell line.

Rob Lambkin-Williams, Alex Mann, Adrian Shephard

|Aug 14, 2020
A COVID-19 human viral challenge model. Learning from experience.

Rob Lambkin-Williams, John P DeVincenzo

|Jul 25, 2020
Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases.

Paul Jacob Bueno de Mesquita, Jonathan Nguyen-Van-Tam, Ben Killingley

|Jun 23, 2018
The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics.

Rob Lambkin-Williams, Nicolas Noulin, Alex Mann

|Feb 08, 2017
The effective rate of influenza reassortment is limited during human infection.

Ashley Sobel Leonard, Micah T McClain, Gavin J D Smith

|Dec 23, 2016
An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.

Rob Lambkin-Williams, Colin Gelder, Richard Broughton

Pageof 1

Frequent Collaborators

1 joint publications

Gavin J D Smith

1 joint publications

Timothy B Stockwell

1 joint publications

Suman R Das

1 joint publications

Geoffrey S Ginsburg